-The Hindu Business Line Industry likely to meet officials today New Delhi: Patients with debilitating knee problems, requiring joint replacement surgeries, would soon regain spring in their steps. The National Pharmaceutical Pricing Authority (NPPA), which capped the prices of coronary stents in February, may cap the prices of knee implants soon. According to a source in the know of the developments, the price of knee implants is likely to be capped with just...
More »SEARCH RESULT
Total Matching Records found : 273
What ails the Centre's generics Rx initiative? -PT Jyothi Datta
-The Hindu Business Line Policymaking has sensibly shifted away from banning the prescription of brand names More than three months after Prime Minister Narendra Modi fired the salvo on getting doctors to prescribe medicines using their generic names, the discussion seems to be on a slow burner. From the strident position that all doctors will have to prescribe medicines using their generic or chemical names, there appears to be a more reconciled acceptance...
More »New Zealand Negotiator at Asia Trade Pact Talks Says Countries Should Analyse TRIPS-Plus -Anoo Bhuyan
-TheWire.in The negotiator’s comments were non-committal but indicated that for now, the RCEP talks have not yet moved decisively into a TRIP-plus scenario. The chief negotiator for New Zealand, at the Asia trade pact talks in Hyderabad this week, made pointed reference to TRIPS-plus (Trade-Related Aspects of Intellectual Property Rights) provisions, saying that while the TRIPS agreement on intellectual property rights was sufficient, it was up to the countries to analyse whether...
More »GST fear: Drug-makers expect shortage of medicines
-The Times of India NEW DELHI: With just a day to go before the roll out of goods and services tax (GST) in India from July 1, the country's drug industry fears that there may be a temporary shortage of medicines as many traders and chemists are yet to comply with the norms. Though the All India Organisation of Chemists and Druggists, which represents over 8 lakh chemists, has assured the government...
More »Can doctors judge best quality in medicines? -Jyotsna Singh
-The Hindu Doctors’ objections to prescribing medicines by generic names fly in the face of a recent report on substandard drugs In a surprise move on April 17, Prime Minister Narendra Modi announced that his government will soon make it mandatory for doctors to prescribe medicines by generic names. The decision was to ensure drug prices remain affordable and patients get a wider bouquet of options instead of being forced to...
More »
